MSN - Profile
✉ Email this page to a colleague
Drugs and US Patents for MSN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Msn | PLERIXAFOR | plerixafor | SOLUTION;SUBCUTANEOUS | 211901-001 | Jul 24, 2023 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Msn | HALOPERIDOL | haloperidol | TABLET;ORAL | 216004-002 | Nov 18, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Msn Labs Pvt Ltd | LACOSAMIDE | lacosamide | TABLET;ORAL | 204921-004 | Mar 17, 2022 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Msn | LISDEXAMFETAMINE DIMESYLATE | lisdexamfetamine dimesylate | TABLET, CHEWABLE;ORAL | 218306-004 | Feb 2, 2024 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Msn | TIAGABINE HYDROCHLORIDE | tiagabine hydrochloride | TABLET;ORAL | 214816-002 | Nov 16, 2021 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Msn | OBETICHOLIC ACID | obeticholic acid | TABLET;ORAL | 215017-001 | May 30, 2023 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Msn | ROSUVASTATIN CALCIUM | rosuvastatin calcium | TABLET;ORAL | 208898-001 | Nov 22, 2017 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |